---> NEWS NEWS NEWS NEWS NEWS <---
Friday November 7, 7:30 pm Eastern Time
Company Press Release
Successful Expansion of the MedCare Program Continues; New Sites to Open in
Arizona with Dr. William Crisp and in Ohio with Dr. Gregory Haselhuhn
Additional Openings in Texas, Connecticut and Florida Planned Before Year End
MedCare Expands Senior Management Team with the Addition of Mr. Greg Wujek, Who Joins as
Vice President of Managed Care
NAPERVILLE, Ill., Nov. 7 /PRNewswire/ -- MedCare Technologies, Inc. (OTC Bulletin Board: MCAR - news) today announced
plans to establish two additional MedCare Program centers in Phoenix, Arizona, and in Toledo, Ohio, for the treatment of
patents suffering from urinary incontinence using MedCare's proprietary non-drug, non-surgical treatment program. The
MedCare Program in Phoenix will be under the auspices of Dr. William Crisp and the Toledo program will be in conjunction
with Dr. Gregory Haselhuhn and Center Urology Associates, Inc., a multi-physician urology practice affiliated with The
University of Toledo with 6 board certified urologists and 3 offices. ''We are both excited and flattered to have such high
caliber medical professionals joining our ever growing roster of physicians throughout the nation,'' said Jeff Aronin,
President and Chief Operating Officer of MedCare Technologies. ''But what we're most excited about is the positive impact
that we're making in the lives of incontinence sufferers who now have a risk free treatment option with the MedCare
Program. Prior to our program, millions of sufferers resorted to absorbent products or contended with surgical and
pharmacological treatment options and their complications and side effect profiles.''
MedCare announces the appointment of Mr. Greg Wujek as Vice President of Managed Care. Mr. Wujek has over 10 years of
healthcare experience, primarily in sales and marketing to the managed care market. Prior to joining MedCare, Mr. Wujek held
the position of Vice President of Sales at SMG Marketing Group, a consulting firm to the healthcare industry, and was a
Director of Managed Care at Forest Laboratories, an international marketer of ethical pharmaceuticals. Mr. Wujek's
responsibilities at MedCare Technologies will include the development and negotiation of unique reimbursement and
marketing strategies in managed care (IPA, staff, practice management companies), long term care, integrated health
networks (provider networks, physician practice management companies), hospitals, Medicare/Medicaid, and fee for service.
''The addition of Greg Wujek to our senior management team is a significant step forward for MedCare,'' said Mr. Harmel S.
Rayat, Chairman and Chief Executive Officer of MedCare Technologies. ''People in managed care and insurance companies are
intelligent and progressive thinking. It won't take them too long to realize that significant savings are possible by placing
MedCare's risk free and highly successful treatment program as a first line treatment method rather than paying for costly
conventional treatment options, such as surgery which often requires hospitalization and has potential risks and
complications.''
MedCare Technologies has developed a cost effective, non-drug, non- surgical and non-invasive system for the care and
treatment of patents suffering from urinary incontinence. MedCare's proprietary treatment protocol does not require FDA
approval, is covered by most health insurance plans and results in the reduction or complete elimination of 70% to 100% of
the most commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly and often
unsuccessful or inadequate, MedCare's treatment program is completely risk free and has a three year history with a proven
success rate in excess of 85%. MedCare Technologies offers a multi- modality program based on behavioral techniques and
neuromuscular electromyography biofeedback. The MedCare Program is designed to mobilize and strengthen various
sensory-response systems and is based on operant conditioning strategies whereby specific physiological responses are
progressively shaped, strengthened and coordinated.
Numerous studies have been completed to determine the prevalence of urinary incontinence in the general population. The
results of one study completed at Emory University in Atlanta, GA, concluded that the prevalence of UI was 43.6% among
women and 20.9% among men. In another study of 3,638 patients over age 20, 1908 women and 922 men completed an
anonymous questionnaire. A reported 43% of women and 11% of men had current UI. Almost 75% of these patients had not
informed a health professional, but more than one third of these said they would see a physician if treatment were available.
Affecting some 25 million Americans, UI is a $16 billion market and accounts for almost half of all nursing home admissions.
Despite being one of the most prevalent medical conditions in health care today, with almost half of all women being
affected at some point, UI remains a vastly under- serviced and over-looked marketplace.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements which are other than statements of historical facts. These
statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance,
changes in technology, changes in insurance reimbursement, economic conditions, the impact of competition and pricing,
government regulation, and other risks defined in this document and in statements filed from time to time with the
Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or
on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which
may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after the date hereof. |
